Adage Capital Partners’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-85,088
| Closed | -$6.42M | – | 922 |
|
|
2024
Q2 | $6.42M | Hold |
85,088
| – | – | 0.01% | 682 |
|
|
2024
Q1 | $5.81M | Sell |
85,088
-65,000
| -43% | -$4.44M | 0.01% | 679 |
|
|
2023
Q4 | $9.43M | Buy |
150,088
+18,000
| +14% | +$1.13M | 0.02% | 603 |
|
|
2023
Q3 | $6.73M | Buy |
132,088
+72,000
| +120% | +$3.67M | 0.02% | 629 |
|
|
2023
Q2 | $3M | Sell |
60,088
-374,912
| -86% | -$18.7M | 0.01% | 715 |
|
|
2023
Q1 | $16.3M | Sell |
435,000
-360,000
| -45% | -$13.5M | 0.04% | 487 |
|
|
2022
Q4 | $38.1M | Buy |
795,000
+695,000
| +695% | +$33.3M | 0.09% | 257 |
|
|
2022
Q3 | $2.4M | Buy |
100,000
+47,100
| +89% | +$1.13M | 0.01% | 843 |
|
|
2022
Q2 | $1.15M | Buy |
+52,900
| New | +$1.15M | ﹤0.01% | 916 |
|